Nadolol

CAS 42200-33-9 8 FDA-DMF suppliersSmall Molecule

Overview

Nadolol is a non-selective beta-adrenergic blocker used in the management of hypertension and angina pectoris. It decreases heart rate, cardiac output, and blood pressure to improve cardiovascular function.

API suppliers (9)

Suppliers of Nadolol backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • FERMION OYFinland1 active DMF
  • Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
  • Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
  • FERMION OYFinland1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
  • FERMION OYFinland1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • SYNCHEM CHEMICALS PRIVATE LTD

Therapeutic areas

Cardiovascular

Related APIs

Rivaroxaban
57 suppliers
Apixaban
51 suppliers
Telmisartan
43 suppliers
Empagliflozin
42 suppliers
Clopidogrel
40 suppliers
Olmesartan Medoxomil
38 suppliers
Valsartan
37 suppliers
Amlodipine
34 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo